FDA approves Sun's generic Prandin
This article was originally published in Scrip
Executive Summary
Sun Pharmaceutical Industries has received final approval for its ANDA for a generic version of Novo Nordisk's diabetes drug Prandin (repaglinide), paving the way for a launch of the product in the US.